Skip to main content
Clinical Trials/NCT00763724
NCT00763724
Completed
Not Applicable

A Propensity-Matched Retrospective Cohort Study of Antidepressant Drug Exposure and Risk of Suicide Attempt in Adults From a Large U.S. Managed Care Population

Eli Lilly and Company0 sites254,432 target enrollmentJune 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
Eli Lilly and Company
Enrollment
254432
Primary Endpoint
Incidence of suicide attempt resulting in medical encounter or hospitalization.
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

The primary objective of the study is to estimate the incidence of suicide attempts resulting in a medical encounter or hospitalization in seven propensity matched cohorts of subjects: patients treated with duloxetine for depression, patients treated with one of three other antidepressants or antidepressant classes (venlafaxine, SSRIs, or TCAs) for depression, patients treated with multiple antidepressants for depression (either concurrently or consecutively), depressed patients with no pharmacologic treatment, and a non-depressed general population sample.

Registry
clinicaltrials.gov
Start Date
June 2008
End Date
November 2009
Last Updated
16 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age 18 years or older at index date
  • Have at least 6 months of continuous enrollment data prior to index date.
  • Have complete medical, facility, and pharmacy records (the latter of which will include complete quantity and days supplied information).

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Incidence of suicide attempt resulting in medical encounter or hospitalization.

Time Frame: Endpoint

Secondary Outcomes

  • Relative risk of suicide attempt resulting in medical encounters or hospitalization(Endpoint)

Similar Trials